Ascendis Pharma Total Non-Operating Income/Expense 2015-2024 | ASND
Ascendis Pharma total non-operating income/expense for the twelve months ending June 30, 2024 was $-0.138B, a 407.37% increase year-over-year.
- Ascendis Pharma annual total non-operating income/expense for 2023 was $-0.02B, a 19.41% increase from 2022.
- Ascendis Pharma annual total non-operating income/expense for 2022 was $-0.017B, a 121.01% decline from 2021.
- Ascendis Pharma annual total non-operating income/expense for 2021 was $0.08B, a 179.35% decline from 2020.